Terpeluk Eva Ronja, Schäfer Jana, Finkler-Schade Christa, Rauch Elke, Rohn Karl, Schuberth Hans-Joachim
Institute for Immunology, University of Veterinary Medicine Foundation, Bünteweg 2, 30559 Hannover, Germany.
Schäfer Horse Breeding, 38159 Vechelde, Germany.
Animals (Basel). 2024 Aug 24;14(17):2459. doi: 10.3390/ani14172459.
The quality of equine colostrum is typically defined by refractometry or the concentration of maternal antibodies. However, the activity of other equine colostral bioactive molecules has not yet been investigated. This study analyzed whether the administration of a fermentation product (SCFP) influences the biological activity of mare colostrum and whether the biological activity of colostrum has a lasting immunomodulating effect for foals. A total of fourteen pregnant mares received 20 g/day of a SCFP for a period of twelve weeks prior to the calculated date of birth (SCFP-group). Twelve pregnant mares without supplementation served as controls (CON). Colostral Brix values were determined within three hours after parturition. The concentration of IgG in blood sera and colostrum samples was determined with an ELISA. The biological activity was determined in a cell growth assay with a porcine epithelial cell line (IPEC-J2). Mares (at three weeks before the calculated date of birth) and foals (at the age of 5-8 months) received a parenteral active vaccination against influenza and tetanus. The administration of SCFP did not alter the mare's serum and colostrum IgG concentrations and did not exert a significant influence on the mares' early response to the vaccination. Growth and diarrhea episodes were comparable between foals of supplemented mares (SCFP) and foals of mares without supplementation (CON). Colostrum samples from SCFP-supplemented mares exhibited heightened biological activity. While SFCP and CON foals did not differ in their early response to vaccination, the vaccination-induced alterations in circulating neutrophilic granulocyte numbers were significantly correlated with the biological colostrum activity. These findings suggest that the supplementation of mares in late gestation with SCFP can enhance the biological activity of colostrum, which subsequently influences the innate immune responses of their offspring in later life.
马初乳的质量通常通过折射法或母体抗体浓度来定义。然而,其他马初乳生物活性分子的活性尚未得到研究。本研究分析了一种发酵产品(SCFP)的施用是否会影响母马初乳的生物活性,以及初乳的生物活性对幼驹是否具有持久的免疫调节作用。在预计出生日期前的十二周内,共有十四匹怀孕母马每天接受20克SCFP(SCFP组)。十二匹未补充的怀孕母马作为对照(CON)。在分娩后三小时内测定初乳的白利糖度值。用ELISA法测定血清和初乳样本中IgG的浓度。在猪上皮细胞系(IPEC-J2)的细胞生长试验中测定生物活性。母马(在预计出生日期前三周)和幼驹(5-8个月龄)接受了针对流感和破伤风的非肠道主动疫苗接种。SCFP的施用并未改变母马血清和初乳中IgG的浓度,也未对母马对疫苗接种的早期反应产生显著影响。补充母马的幼驹(SCFP)和未补充母马的幼驹(CON)之间的生长和腹泻发作情况相当。来自补充SCFP母马的初乳样本表现出更高的生物活性。虽然SCFP和CON幼驹在对疫苗接种的早期反应方面没有差异,但疫苗接种引起的循环中性粒细胞数量变化与初乳生物活性显著相关。这些发现表明,在妊娠后期给母马补充SCFP可以增强初乳的生物活性,这随后会影响其后代在以后生活中的先天免疫反应。